Pituitary adenomas.
This review focuses on recent developments in the treatment of pituitary adenomas. Current treatments include both transcranial and transsphenoidal surgery, the medical treatment specifically for endocrinopathies, and finally, radiation treatments including conventional radiation as well as stereotactic radiosurgery. All these modalities are reviewed.
Andrews
D W
DW
Thomas Jefferson University, Department of Neurosurgery, Philadelphia, PA 19486, USA.
D000172:Acromegaly / Q000209:etiology; D000236:Adenoma / Q000150:complications / Q000175:diagnosis / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D016371:Cranial Irradiation; D003480:Cushing Syndrome / Q000209:etiology; D018491:Dopamine Agonists / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007016:Hypophysectomy; D008297:Male; D010908:Pituitary Hormones, Anterior / Q000097:blood; D010911:Pituitary Neoplasms / Q000150:complications / Q000175:diagnosis / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D015175:Prolactinoma / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy; D016634:Radiosurgery; D012008:Recurrence; D013238:Stereotaxic Techniques
D000970:Antineoplastic Agents; D018491:Dopamine Agonists; D010908:Pituitary Hormones, Anterior; D006854:Hydrocortisone